The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy
- PMID: 16156882
- DOI: 10.1111/j.1468-1293.2005.00318.x
The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy
Abstract
We report two cases in which osteomalacia developed in patients on tenofovir-containing highly active antiretroviral therapy (HAART) in the context of Fanconi syndrome with hypophosphataemia. Bone pain was the presenting feature and myopathy followed in one case. Disability was reversed with withdrawal of the drug and with mineral supplementation. The cases highlight the importance of considering the diagnosis of osteomalacia in patients treated with tenofovir. A possible association with incipient acute renal failure, particularly during nonsteroidal anti-inflammatory drug (NSAID) use, needs further investigation.
Comment in
-
Estimating renal function in patients on tenofovir disoproxil fumarate: suggestions for safer use.HIV Med. 2006 Oct;7(7):484-5. doi: 10.1111/j.1468-1293.2006.00411.x. HIV Med. 2006. PMID: 16925736 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
